Step off our ‘doughnut hole’ deal: AARP ads take on Big Pharma lobbying
Step off our ‘doughnut hole’ deal: AARP ads take on Big Pharma lobbying
AbbVie staves off 6th Humira biosimilar in US
AbbVie staves off 6th Humira biosimilar in US
New AHA/ACC Cholesterol Treatment Guideline Expands Role of LDL Targets
New AHA/ACC Cholesterol Treatment Guideline Expands Role of LDL Targets
Εκστρατεία ενημέρωσης για την LDL χοληστερίνη
Εκστρατεία ενημέρωσης για την LDL χοληστερίνη
Angst about Aimovig pickup and reimbursement overshadows Amgen’s solid quarter
Angst about Aimovig pickup and reimbursement overshadows Amgen’s solid quarter
FDA Approves Humira Biosimilar That Won’t Be Available Until 2023
FDA Approves Humira Biosimilar That Won’t Be Available Until 2023
Is the Biotech Bull Market Over?
Is the Biotech Bull Market Over?
Δυναμική πορεία των βιο-ομοειδών φαρμάκων
Δυναμική πορεία των βιο-ομοειδών φαρμάκων
Being there: Amgen and Novartis roll out first ad campaign for migraine drug Aimovig
Being there: Amgen and Novartis roll out first ad campaign for migraine drug Aimovig
7 drugmakers to watch on Q3 earnings
7 drugmakers to watch on Q3 earnings
Amgen, Novartis and Banner Alzheimer’s Institute Team on 2 Alzheimer’s Prevention Trials
Amgen, Novartis and Banner Alzheimer’s Institute Team on 2 Alzheimer’s Prevention Trials
Global Biopharma Companies Top Forbes’ List of World’s Best Employers
Global Biopharma Companies Top Forbes’ List of World’s Best Employers
Top Pharma News of the Week
Top Pharma News of the Week
Moody’s picks 5 early winners in biosimilar market
Moody’s picks 5 early winners in biosimilar market
FDA Approves Eli Lilly’s Migraine Drug, Which Faces Stiff Market Competition
FDA Approves Eli Lilly’s Migraine Drug, Which Faces Stiff Market Competition
Teva tries to make something out of nothing with Ajovy approval
Teva tries to make something out of nothing with Ajovy approval
